December 17, 2024

Pfizer: No Major Vaccine Shifts in 2025

Pfizer's CEO addressed the impact of potential vaccine policy changes and the nomination of a vaccine skeptic to run the Department of Health and Human Services, highlighting the company's commitment to advancing the right policies and overcoming challenges in the pharmaceutical market.

Reuters

December 16, 2024

AAP Unveils Screening Protocol Changes

New guidelines for congenital heart disease screening recommend a single retest and require ≥95% oxygen saturation in both pre- and post-ductal measurements, aiming to simplify detection while maintaining accuracy.

Conexiant

December 13, 2024

New Vaccine Prevents Severe RSV Illness

A recent study showed the new vaccine was more than 90% effective in the prevention of hospitalizations and emergency department visits due to RSV among those 60 years old or older.

Conexiant

December 11, 2024

Do E-Cigarettes Aid Long-Term Smoking Cessation?

A recent study found that e-cigarette use was associated with lower long-term smoking cessation rates compared to traditional methods like nicotine replacement therapy.

Conexiant

December 11, 2024

Vitamin D Tied to ICU Survival

A study on ICU patients with sepsis-associated acute kidney injury revealed a 41% lower risk of in-hospital mortality with vitamin D supplementation, highlighting the potential benefits of this approach. Source: Frontiers in Medicine

Conexiant

December 09, 2024

Do SGLT2i, GLP-1 RAs Cut Pneumonia, Sepsis Risk?

In the largest real-world study to date, GLP-1 receptor agonists reduced pneumonia risk by 40% in type 2 diabetes patients.

Conexiant

December 06, 2024

COPD Treatment Patterns and Exacerbations: A 4-Year Study

A recent study in the United States revealed low adherence to guideline-directed therapy and underutilization of recommended maintenance therapies among patients newly diagnosed with chronic obstructive pulmonary disease.

Conexiant

December 06, 2024

Influenza and COVID-19 Vaccine Trends Among HCPs in 2023–24

A recent study compared influenza and COVID-19 vaccination coverage among healthcare personnel, revealing significant differences and geographic variability. Learn more about the findings and potential strategies for improving vaccination rates.

Conexiant

December 06, 2024

Can Fostamatinib Improve Hypoxemia in COVID-19?

A recent study evaluated the effectiveness of fostamatinib in hospitalized adults with COVID-19 infections and hypoxemia, finding no significant improvement in oxygen-free days or reduction in mortality.

Conexiant